An early cancer detection service utilizing novel blood analysis through AI technology.



Currently, people need to undergo different screening methods for each type of cancer. This process can be invasive, emotionally stressful, and expensive. Because patients find testing to be stressful and costly, they are not testing early enough making their cancer more difficult to treat.


PFM is developing a single blood test that can detect multiple cancer types at earlier stages. This service is coupled with deep learning technology that enables higher accuracy in early stage detection. This AI-powered technology identifies specific compounds in the blood to detect cancer-associated patterns. PFM aims to increase the accessibility and success rate of earlier cancer detection, resulting in immediate treatment worldwide.


Nobuhiro Andrew Kawai (Andy) 
Healthcare Service Business Unit


Read our stories

16 startups join Moon to build for traction, receive real feedback from customers as quickly as possible, and potentially earn funding.

Read More

In this Moon Talk!, we hear from two entrepreneurs in the emerging GX industry as they share their key learnings.

Read More

Audio content can easily lose its intended effect when narrated by someone other than the other. VOOX aims to change that.

Read More

Subscribe to our newsletter